Jan 08, 2020
Martin Jönsson Appointed New CEO of AlzeCure Pharma
Jan 07, 2020
Golden Bull Limited Has Been Notified by Nasdaq it is not in Compliance with Listing Rules
Jan 07, 2020
EXFO Renews Normal Course Issuer Bid
Dec 30, 2019
Azelio's Verification Project in Morocco Delivers First Electricity
Dec 23, 2019
Colorcon, Inc. Launches On-Dose Authentication Platform From Applied DNA Sciences
Dec 23, 2019
Crypto Price Index Meets Demand for a Stable Crypto Asset with its Token Incorporating the Same Founding Principles as Global Market Indices
Dec 23, 2019
The pivotal Phase 3 Clinical Trial NefIgArd Part A Fully Recruited
Dec 21, 2019
FDA Grants Avatrombopag Orphan Drug Designation for the Treatment of Chemotherapy-induced Thrombocytopenia
Dec 20, 2019
TriMas Completes the Sale of Its Lamons Division
Dec 20, 2019
Callon and Carrizo Complete Merger
Dec 20, 2019
NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study
Dec 20, 2019
Correction: Azelio Initiates Collaboration in Oman
Dec 20, 2019
Azelio Initiates Collaboration in Oman
Dec 19, 2019
Completion of Recruitment of Part A of the Neflgard Pivotal Phase 3 Clinical Trial by Year End
Dec 18, 2019
Mycronic Moves up to Nasdaq Large Cap
Dec 18, 2019
Wix Increases Foothold in New York City with Expanded Office and Growing Team
Dec 18, 2019
Quarterhill Announces Filing of Form 25 and Application to List Common Shares on OTCQX
Dec 17, 2019
CUI Global Regains Nasdaq Listing Compliance
Dec 17, 2019
China IND Approval Triggers $5 Million Milestone Payment From Everest Medicines
Dec 16, 2019
NeuroVive Announces Settlement in Dispute With CicloMulsion AG